Pending.AI

Pending.AI is developing artificial intelligence solutions to enable scientists in the pharmaceutical industry to design, manufacture, and test new drugs for treating diseases.Current research areas include: de novo drug design; structure-based drug design; high-throughput chemistry; and synthesis planning.As scientific data becomes increasingly abundant and accessible, the importance of artificial intelligence continues to grow. To deliver high-quality, evidence-based solutions, AI models are trained on large federated datasets containing millions of data points. AI-based solutions can be used to augment the cognitive capabilities of individual scientists and teams, empowering them to make more informed decisions in drug design.